Skip to main content
. 2020 Nov 24;12(3):8867. doi: 10.4081/or.2020.8867

Table 3.

Microbial findings in 30 patients with polymicrobial PJI.

All, n=76 (%) DTT, n=45 Non-DTT (n=31)
DTT, n=21 (%) Non-DTT, n=24 (%)
Gram-positive bacteria 52 (68.4) 9 (42.8) 20 (83.3) 23 (74.2)
    Staphylococcus spp. 30 (39.4) 7 (33.3) 11 (45.8) 12 (38.7)
    Staphylococcus aureus 14 (18.4) 4(19) 5 (20.8) 5 (16.1)
    Staphylococcus epidermidis 7 (9.2) 3 (14.3) 2 (8.3) 2 (6.4)
    Coagulase-negative staphylococci 9 (11.8) - 4 (16.6) 5 (16.1)
    Streptococcus spp. 6 (7.9) - 3 (12.5) 3 (9.6)
    Enterococcus spp. 12 (15.8) 2 (9.5) 5 (20.8) 5 (16.1)
    Other1 4 (5.2) - 1 (4.1) 3 (9.6)
Gram-negative bacteria 19(25) 7 (33.3) 4 (16.6) 8 (25.8)
    Escherichia coli 6 (7.9) 3 (14.3) - 3 (9.6)
    Enterobacteriaceae spp.2 6 (7.9) 1 (4.7) 2 (8.3) 3 (9.6)
    Pseudomonas aeruginosa 5 (6.6) 2 (9.5) 1 (4.1) 2 (6.4)
    Proteus mirabilis 1 (1.3) 1 (4.7) - -
    Other3 1 (1.3) - 1 (4.1) -
Candida spp. 5 (6.6) 5 (23.8) - -

Data presented as absolute Number (Percentage). Abbreviations: DTT difficult-to-treat. 1Including Bacillus spp., Corynebacterium spp., Leuconostoc, Proprionbacterium spp. 2Including Klebsiella (n=3), Acinetobacter spp. Citrobacter spp., Enterobacter spp. 3Aeromonas spp.